Loading...
XSHG
603108
Market cap1.28bUSD
Dec 05, Last price  
15.04CNY
1D
1.42%
1Q
-11.84%
Jan 2017
-11.43%
IPO
201.40%
Name

Shanghai Runda Medical Technology Co Ltd

Chart & Performance

D1W1MN
XSHG:603108 chart
P/E
164.24
P/S
1.09
EPS
0.09
Div Yield, %
0.66%
Shrs. gr., 5y
1.17%
Rev. gr., 5y
3.34%
Revenues
8.31b
-9.13%
631,452,386772,338,8321,025,889,5261,358,503,3231,628,641,8682,164,688,8404,318,809,8415,964,339,2237,051,950,1827,069,156,2908,860,108,02710,494,418,6949,147,372,7198,311,780,357
Net income
55m
-79.77%
54,495,55558,794,70767,940,01475,162,10491,760,316116,427,774219,186,704261,953,796511,101,489503,830,450598,200,717655,110,069273,296,49555,280,607
CFO
647m
-19.31%
038,700,97231,623,69036,114,224000538,902,960246,678,613323,441,186371,112,6900801,750,549646,947,379
Dividend
Jul 19, 20240.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shanghai Runda Medical Technology Co., Ltd. provides integrated medical laboratory services in China. It offers platform supply, laboratory design/renovation, laboratory standardization, and information management system services; medical solutions to help healthcare professionals in the areas of biochemistry, diabetes, POCT, immunoassay analyzer, and molecular biology diagnosis; professional technical services; and logistic services. The company was founded in 1999 and is based in Shanghai, China.
IPO date
May 27, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT